These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 22442756)

  • 1. Novel biomarkers and therapeutic targets for optimizing the therapeutic management of melanomas.
    Mimeault M; Batra SK
    World J Clin Oncol; 2012 Mar; 3(3):32-42. PubMed ID: 22442756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies.
    Mimeault M; Batra SK
    Mol Aspects Med; 2014 Oct; 39():3-32. PubMed ID: 23994756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting of cancer stem/progenitor cells plus stem cell-based therapies: the ultimate hope for treating and curing aggressive and recurrent cancers.
    Mimeault M; Batra SK
    Panminerva Med; 2008 Mar; 50(1):3-18. PubMed ID: 18427384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent gene products and molecular pathways altered in prostate cancer- and metastasis-initiating cells and their progenies and novel promising multitargeted therapies.
    Mimeault M; Batra SK
    Mol Med; 2011; 17(9-10):949-64. PubMed ID: 21607288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New advances on critical implications of tumor- and metastasis-initiating cells in cancer progression, treatment resistance and disease recurrence.
    Mimeault M; Batra SK
    Histol Histopathol; 2010 Aug; 25(8):1057-73. PubMed ID: 20552555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent deregulations in the hedgehog signaling network and cross-talks with the epidermal growth factor receptor pathway involved in cancer progression and targeted therapies.
    Mimeault M; Batra SK
    Pharmacol Rev; 2010 Sep; 62(3):497-524. PubMed ID: 20716670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent progress on normal and malignant pancreatic stem/progenitor cell research: therapeutic implications for the treatment of type 1 or 2 diabetes mellitus and aggressive pancreatic cancer.
    Mimeault M; Batra SK
    Gut; 2008 Oct; 57(10):1456-68. PubMed ID: 18791122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathobiological implications of the expression of EGFR, pAkt, NF-κB and MIC-1 in prostate cancer stem cells and their progenies.
    Mimeault M; Johansson SL; Batra SK
    PLoS One; 2012; 7(2):e31919. PubMed ID: 22384099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Future perspectives in melanoma research: meeting report from the "Melanoma Bridge": Napoli, December 3rd-6th 2014.
    Ascierto PA; Atkins M; Bifulco C; Botti G; Cochran A; Davies M; Demaria S; Dummer R; Ferrone S; Formenti S; Gajewski TF; Garbe C; Khleif S; Kiessling R; Lo R; Lorigan P; Arthur GM; Masucci G; Melero I; Mihm M; Palmieri G; Parmiani G; Puzanov I; Romero P; Schilling B; Seliger B; Stroncek D; Taube J; Tomei S; Zarour HM; Testori A; Wang E; Galon J; Ciliberto G; Mozzillo N; Marincola FM; Thurin M
    J Transl Med; 2015 Nov; 13():374. PubMed ID: 26619946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular biomarkers of cancer stem/progenitor cells associated with progression, metastases, and treatment resistance of aggressive cancers.
    Mimeault M; Batra SK
    Cancer Epidemiol Biomarkers Prev; 2014 Feb; 23(2):234-54. PubMed ID: 24273063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cirsiliol Suppressed Epithelial to Mesenchymal Transition in B16F10 Malignant Melanoma Cells through Alteration of the PI3K/Akt/NF-κB Signaling Pathway.
    Prasad P; Vasas A; Hohmann J; Bishayee A; Sinha D
    Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30708951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells.
    Mimeault M; Batra SK
    J Cell Mol Med; 2013 Jan; 17(1):30-54. PubMed ID: 23301832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential therapeutic targets of epithelial-mesenchymal transition in melanoma.
    Pearlman RL; Montes de Oca MK; Pal HC; Afaq F
    Cancer Lett; 2017 Apr; 391():125-140. PubMed ID: 28131904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in cancer stem/progenitor cell research: therapeutic implications for overcoming resistance to the most aggressive cancers.
    Mimeault M; Hauke R; Mehta PP; Batra SK
    J Cell Mol Med; 2007; 11(5):981-1011. PubMed ID: 17979879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VEGF and VEGFR-2 immunohistochemistry in human melanocytic naevi and cutaneous melanomas.
    Pisacane AM; Risio M
    Melanoma Res; 2005 Feb; 15(1):39-43. PubMed ID: 15714119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The molecular pathology of cutaneous melanoma.
    Bogenrieder T; Herlyn M
    Cancer Biomark; 2010; 9(1-6):267-86. PubMed ID: 22112480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RaLP, a new member of the Src homology and collagen family, regulates cell migration and tumor growth of metastatic melanomas.
    Fagiani E; Giardina G; Luzi L; Cesaroni M; Quarto M; Capra M; Germano G; Bono M; Capillo M; Pelicci P; Lanfrancone L
    Cancer Res; 2007 Apr; 67(7):3064-73. PubMed ID: 17409413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complex oncogenic signaling networks regulate brain tumor-initiating cells and their progenies: pivotal roles of wild-type EGFR, EGFRvIII mutant and hedgehog cascades and novel multitargeted therapies.
    Mimeault M; Batra SK
    Brain Pathol; 2011 Sep; 21(5):479-500. PubMed ID: 21615592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HPV: Molecular pathways and targets.
    Gupta S; Kumar P; Das BC
    Curr Probl Cancer; 2018; 42(2):161-174. PubMed ID: 29706467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.